MEDICAL DEVICES, TECHNOLOGIES, EQUIPMENT, SUPPLIES
1 min.Read

OsteoCentric Technologies Introduces THEIR Mechanical Integration UnifiMI Technology to the $7.6b Spinal Fusion Market

Mechanical Integration, the first new method to secure implants to bone since the introduction of osseointegration in the 1970s, is designed to address implant instability in normal and compromised bone

OsteoCentric Technologies, the pioneer of Mechanical Integration, announces the execution of a private label agreement with Altus Spine which will propel their subsidiary, OsteoCentric Spine, LLC, into the pedicle screw fixation space.

The agreement will allow OsteoCentric to marry its Mechanical Integration technology platform, UnifiMITM, to an existing FDA-cleared system.

OsteoCentric Technologies plans to enter the spinal fusion market segment in Q2 2022, and introduce its revolutionary minimally invasive method of instantly securing Pedicle Fastener implants to bone.

This new UnifiMI product launch comes on the heels of announcing the company’s acquisition of the Integrity-SITM Fusion System from Lincotek/Mayo Clinic in October 2021. “Our expansion into spine establishes an additional cornerstone for us as we continue to broaden the Mechanical Integration platform across the spine, sports, total joint reconstruction, extremities, oncology, trauma, veterinary, and dental segments. Our successful conversion of KOL surgeons at dozens of leading Trauma Teaching Centers provides a clear roadmap to achieve the same disruption in the $7.6B US spinal fusion market segment[1],” says Gavin Sontag, Chief Marketing Officer at OsteoCentric.

UnifiMI‘s clinical value, user demand, and market penetration potential have been proven over the last 24 months. With the announcement of this agreement, OsteoCentric plans to prove how quickly and efficiently a standard interference fit implant can be upgraded to a Mechanically Integrated version in the spine space.

“There have been no significant design changes to our method for securing pedicle screws to bone in the last several decades,” says Dr. Kade Huntsman, MD, a board-certified orthopedic surgeon specializing in the treatment of the spine and practicing at St. Mark’s Hospital in Salt Lake City, Utah. “I can attest that the failure of the pedicle screw-bone interface is a common occurrence. Once launched, OsteoCentric’s new method of fixating pedicle screws will be a game-changer that addresses these failures and completely disrupts the market. I am confident it will soon become the new standard of care.”

Additionally, OsteoCentric is pleased to be listed by MedTech Outlook as a Top 10 Orthopedic Solution Provider. The list includes companies that make a significant contribution to the healthcare sector, as well as those that address challenges in treating patients suffering from orthopedic issues.

SourceOsteoCentric Technologies

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

0
Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

0
Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

0
Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

0
The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

0
“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”

About us

Medical Device News Magazine

Welcome to Medical Device News Magazine, a digital publication providing up to the minute medical device news and biotechnology news.

Need to know more?

Contact us

Navigation

Florida, New York
United States
Phone Number: 1.561.316.3330